These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34225015)

  • 1. Energy metabolism in major depressive disorder: Recent advances from omics technologies and imaging.
    Gu X; Ke S; Wang Q; Zhuang T; Xia C; Xu Y; Yang L; Zhou M
    Biomed Pharmacother; 2021 Sep; 141():111869. PubMed ID: 34225015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder.
    Martins-de-Souza D
    Dialogues Clin Neurosci; 2014 Mar; 16(1):63-73. PubMed ID: 24733971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Application of Omics Technologies in the Research of Neurotoxicology.
    Shao W; Li H
    Methods Mol Biol; 2021; 2326():143-154. PubMed ID: 34097266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of "omics" in bioremediation--a review].
    Lv Y; Tian Y; Zheng T
    Wei Sheng Wu Xue Bao; 2011 May; 51(5):579-85. PubMed ID: 21800618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Metabolomics and Proteomics Analysis of Major Depression in an Animal Model: Perturbed Energy Metabolism in the Chronic Mild Stressed Rat Cerebellum.
    Shao WH; Chen JJ; Fan SH; Lei Y; Xu HB; Zhou J; Cheng PF; Yang YT; Rao CL; Wu B; Liu HP; Xie P
    OMICS; 2015 Jul; 19(7):383-92. PubMed ID: 26134254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seeking an objective diagnosis of depression.
    Bilello JA
    Biomark Med; 2016 Aug; 10(8):861-75. PubMed ID: 27415130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics study for interpretation of genome-wide association study.
    Akiyama M
    J Hum Genet; 2021 Jan; 66(1):3-10. PubMed ID: 32948838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis of inborn errors of metabolism by an integrative "multi-omics" approach: A perspective encompassing genomics, transcriptomics, and proteomics.
    Stenton SL; Kremer LS; Kopajtich R; Ludwig C; Prokisch H
    J Inherit Metab Dis; 2020 Jan; 43(1):25-35. PubMed ID: 31119744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic mild stress leads to aberrant glucose energy metabolism in depressed Macaca fascicularis models.
    Qin Y; Jiang X; Li W; Li J; Tian T; Zang G; Fang L; Zhou C; Xu B; Gong X; Huang C; Yang X; Bai M; Fan L; Xie P
    Psychoneuroendocrinology; 2019 Sep; 107():59-69. PubMed ID: 31108306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single cell analysis: the new frontier in 'omics'.
    Wang D; Bodovitz S
    Trends Biotechnol; 2010 Jun; 28(6):281-90. PubMed ID: 20434785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data analysis methods for defining biomarkers from omics data.
    Li C; Gao Z; Su B; Xu G; Lin X
    Anal Bioanal Chem; 2022 Jan; 414(1):235-250. PubMed ID: 34951658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assimilation of 'omics' strategies to study the cuticle layer and suberin lamellae in plants.
    Cohen H; Szymanski J; Aharoni A; Dominguez E
    J Exp Bot; 2017 Nov; 68(19):5389-5400. PubMed ID: 29040673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omics and cachexia.
    Twelkmeyer B; Tardif N; Rooyackers O
    Curr Opin Clin Nutr Metab Care; 2017 May; 20(3):181-185. PubMed ID: 28230703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention.
    Aleksandrova K; Egea Rodrigues C; Floegel A; Ahrens W
    Curr Obes Rep; 2020 Sep; 9(3):219-230. PubMed ID: 32594318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
    Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
    Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omics Technologies for Microalgae-based Fuels and Chemicals: Challenges and Opportunities.
    Khan AZ; Shahid A; Cheng H; Mahboob S; Al-Ghanim KA; Bilal M; Liang F; Nawaz MZ
    Protein Pept Lett; 2018; 25(2):99-107. PubMed ID: 29359650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-omics approaches to improve malaria therapy.
    Zhou M; Varol A; Efferth T
    Pharmacol Res; 2021 May; 167():105570. PubMed ID: 33766628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of metabolomics and transcriptomics in nanotoxicity studies.
    Shin TH; Lee DY; Lee HS; Park HJ; Jin MS; Paik MJ; Manavalan B; Mo JS; Lee G
    BMB Rep; 2018 Jan; 51(1):14-20. PubMed ID: 29301609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using omics approaches to understand pulmonary diseases.
    Kan M; Shumyatcher M; Himes BE
    Respir Res; 2017 Aug; 18(1):149. PubMed ID: 28774304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.